Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
YourBio Health, a pioneer in remote blood collection technology, announced today the appointments of Michael Mina, M.D., Ph.D. as Chief Scientific Officer, Chester Robson D.O., as Chief Medical ...
Data reinforce dose-dependent mechanism with IMNN-001 100mg/m 2 dose associated with 20% increase in IL-12 levels compared to 79mg/m 2 dose. Results from OVATION 2 Study continue ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu ...
Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published ...
Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...
The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback